Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
258.75
-1.52 (-0.58%)
At close: Mar 28, 2025, 4:00 PM
261.86
+3.11 (1.20%)
After-hours: Mar 28, 2025, 7:17 PM EDT
Insulet Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$531,179
Profits / Employee
$107,256
Market Cap
18.17B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3,900 | 900 | 30.00% |
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
PODD News
- 9 days ago - Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections - Business Wire
- 10 days ago - Insulet Announces Pricing of Senior Notes Due 2033 - Business Wire
- 10 days ago - Insulet Announces Proposed Financing Transactions - Business Wire
- 11 days ago - Insulet Leans Bullish (Technical Analysis) - Seeking Alpha
- 18 days ago - Insulet to Host Investor Day on June 5, 2025 - Business Wire
- 4 weeks ago - Insulet Sales Keep Rising - FXEmpire
- 5 weeks ago - Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: Analyst - Benzinga
- 5 weeks ago - Insulet Corporation (PODD) Q4 2024 Earnings Call Transcript - Seeking Alpha